Tim Conway results 15
· Newest (Page 1/1, per page 25)
Author: Tim Conway ×Clear All Filters
Search Results
Alzheimer’s disease (AD) is the most common cause of dementia, for which there is no curative treatment and few disease-modifying therapies. The vast majority of AD is late onset (LOAD) without a specific genetic cause, although many genetic and non-genetic risk factors have been identified. One of the most significant modifiable risk factors is diet/lifestyle, with type-2 diabetes mellitus (T2DM) increasing LOAD risk by over...
There has been much interest in the use of cell culture models of neurones, to avoid the animal welfare and cost issues of using primary and human-induced pluripotent stem cell (hiPSC)-derived neurones respectively. The human neuroblastoma cell line, SH-SY5Y, is extensively used in laboratories as they can be readily expanded, are of low cost and can be differentiated into neuronal-like cells. However, much debate remains as t...
Dissolved iron (dFe) is an essential micronutrient for phytoplankton, with vanishingly low oceanic dissolved concentrations (pico- to nanomoles per kg) known to limit growth—and thus influence primary productivity and carbon cycling—over much of the surface ocean. However, because of the considerable challenges associated with contamination-free sample collection and accurate analysis of such low dFe concentrations, the first...
This special issue of Oceanography celebrates the transformational findings of the international GEOTRACES program in chemical oceanography, 20 years after drafting of the GEOTRACES Science Plan in 2004 (GEOTRACES Planning Group, 2006). With the section cruise phase of the program ending soon, and a planned pivot toward smaller-scale process studies, this is an opportune time to look back at the achievements of GEOTRACES duri...
Prolonging survival in good health is a fundamental societal goal. However, the leading determinants of disability-free survival in healthy older people have not been well established. Data from ASPREE, a bi-national placebo-controlled trial of aspirin with 4.7 years median follow-up, was analysed. At enrolment, participants were healthy and without prior cardiovascular events, dementia or persistent physical disability. Disab...
Previous1Next